-transparent.png){kind=logo}
The effect of intraovarian injection of benzo(a)pyrene (BP) or one of three metabolites: +7,8-oxide (7,8-O), (-)-dihydrodiol (DHD), and (+)-diol-epoxide-2 (DE2) on ovarian volume, weight, and follicle number was investigated in DBA/2N (D2), C57BL/6N (B6), and (DBA/2N x C57BL/6N)F1 (F1) mice. Female mice, 6 to 8 weeks old, were treated by injection into the right ovary with the indicated compound (10 micrograms in 1 microL DMSO). The left ovary was untreated. Two weeks following treatment both ovaries were removed, fixed in Bouin's medium, serially sectioned, and stained with hematoxylin and eosin. Right ovarian weight was decreased in D2 mice treated with BP (P less than 0.01 and DHD (P less than 0.01). Left ovarian weight was increased in D2 mice treated with DE2 (P less than 0.05). BP decreased right ovarian volume in D2 (P less than 0.01) and F1 (P less than 0.01) mice. 7,8-O decreased right ovarian volume in D2 mice (P less than 0.05). DHD decreased right ovarian volume in D2 (P less than 0.01) and F1 (P less than 0.05) mice. DE2 decreased right ovarian volume in D2 (P less than 0.01) and F1 (P less than 0.01) mice. Left ovarian volume was increased in B6 (P less than 0.01) and D2 (P less than 0.05) mice treated with DE2. The number of small follicles was decreased in D2, B6, and F1 mice treated with DE2 (P less than 0.01). BP and DHD also decreased small follicle number in D2 and F1 mice (P less than 0.01). The number of growing follicles was decreased in B6, D2, and F1 mice treated with DE2 (P less than 0.01). Treatment with DHD decreased the number of growing follicles in D2 mice (P less than 0.05). The number of antral follicles was reduced in F1 mice treated with BP (P less than 0.05), DHD (P less than 0.01), and DE2 (P less than 0.01). The number of antral follicles was also reduced in B6 mice treated with DE2 (P less than 0.01) and in D2 mice treated with DHD (P less than 0.05) and D2 mice treated with DE2 (P less than 0.01). These experiments suggest that toxic effects to one ovary may result in compensatory hypertrophy of the contralateral ovary. Morphometric analysis of the ovary, including ovarian volume, represents a useful objective measure of ovarian toxicity.
D R Mattison, and
H Singh, and
K Takizawa, and
P J Thomford
October 2020,
Toxicology letters,
D R Mattison, and
H Singh, and
K Takizawa, and
P J Thomford
May 1977,
Biochemical pharmacology,
D R Mattison, and
H Singh, and
K Takizawa, and
P J Thomford
March 1997,
Canadian journal of physiology and pharmacology,
D R Mattison, and
H Singh, and
K Takizawa, and
P J Thomford
September 1976,
Mutation research,
D R Mattison, and
H Singh, and
K Takizawa, and
P J Thomford
July 2018,
Human & experimental toxicology,
D R Mattison, and
H Singh, and
K Takizawa, and
P J Thomford
April 1977,
Cancer research,
D R Mattison, and
H Singh, and
K Takizawa, and
P J Thomford
May 2023,
Toxicology and industrial health,
D R Mattison, and
H Singh, and
K Takizawa, and
P J Thomford
January 2010,
Journal of toxicology and environmental health. Part A,
D R Mattison, and
H Singh, and
K Takizawa, and
P J Thomford
January 1967,
Texas reports on biology and medicine,
D R Mattison, and
H Singh, and
K Takizawa, and
P J Thomford
November 1981,
Cancer research,
